Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200480981> ?p ?o ?g. }
- W4200480981 endingPage "132" @default.
- W4200480981 startingPage "119" @default.
- W4200480981 abstract "Mitochondria are key organelles involved in cellular survival, differentiation, and death induction. In this regard, mitochondrial morphology and/or function alterations are involved in stress-induced adaptive pathways, priming mitochondria for mitophagy or apoptosis induction. We have previously shown that the mitochondriotropic antioxidant AntiOxCIN4 (100 μM; 48 h) presented significant cytoprotective effect without affecting the viability of human hepatoma-derived (HepG2) cells. Moreover, AntiOxCIN4 (12.5 μM; 72 h) caused a mild increase of reactive oxygen species (ROS) levels without toxicity to primary human skin fibroblasts (PHSF). As Nrf2 is a master regulator of the oxidative stress response inducing antioxidant-encoding gene expression, we hypothesized that AntiOxCIN4 could increase the resistance of human hepatoma-derived HepG2 to oxidative stress by Nrf2-dependent mechanisms, in a process mediated by mitochondrial ROS (mtROS). Here we showed that after an initial decrease in oxygen consumption paralleled by a moderate increase in superoxide anion levels, AntiOxCIN4 led to a time-dependent Nrf2 translocation to the nucleus. This was followed later by a 1.5-fold increase in basal respiration and a 1.2-fold increase in extracellular acidification. AntiOxCIN4 treatment enhanced mitochondrial quality by triggering the clearance of defective organelles by autophagy and/or mitophagy, coupled with increased mitochondrial biogenesis. AntiOxCIN4 also up-regulated the cellular antioxidant defense system. AntiOxCIN4 seems to have the ability to maintain hepatocyte redox homeostasis, regulating the electrophilic/nucleophilic tone, and preserve cellular physiological functions. The obtained data open a new avenue to explore the effects of AntiOxCIN4 in the context of preserving hepatic mitochondrial function in disorders, such as NASH/NAFLD and type II diabetes." @default.
- W4200480981 created "2021-12-31" @default.
- W4200480981 creator A5004453115 @default.
- W4200480981 creator A5022559731 @default.
- W4200480981 creator A5032141337 @default.
- W4200480981 creator A5048396749 @default.
- W4200480981 creator A5053538919 @default.
- W4200480981 creator A5072661653 @default.
- W4200480981 creator A5075910701 @default.
- W4200480981 creator A5087748959 @default.
- W4200480981 creator A5088567564 @default.
- W4200480981 creator A5088843394 @default.
- W4200480981 date "2022-02-01" @default.
- W4200480981 modified "2023-10-11" @default.
- W4200480981 title "Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage" @default.
- W4200480981 cites W1518086527 @default.
- W4200480981 cites W1775832387 @default.
- W4200480981 cites W1988593777 @default.
- W4200480981 cites W1992532731 @default.
- W4200480981 cites W1996336202 @default.
- W4200480981 cites W1998858810 @default.
- W4200480981 cites W2004743851 @default.
- W4200480981 cites W2005014916 @default.
- W4200480981 cites W2009715420 @default.
- W4200480981 cites W2010530906 @default.
- W4200480981 cites W2011170381 @default.
- W4200480981 cites W2017119076 @default.
- W4200480981 cites W2026261400 @default.
- W4200480981 cites W2027542963 @default.
- W4200480981 cites W2030408524 @default.
- W4200480981 cites W2030751836 @default.
- W4200480981 cites W2041813594 @default.
- W4200480981 cites W2047995240 @default.
- W4200480981 cites W2049016912 @default.
- W4200480981 cites W2052239120 @default.
- W4200480981 cites W2064341136 @default.
- W4200480981 cites W2075535173 @default.
- W4200480981 cites W2076598575 @default.
- W4200480981 cites W2080270879 @default.
- W4200480981 cites W2081303452 @default.
- W4200480981 cites W2089611683 @default.
- W4200480981 cites W2096163228 @default.
- W4200480981 cites W2104381422 @default.
- W4200480981 cites W2110374590 @default.
- W4200480981 cites W2111567059 @default.
- W4200480981 cites W2124733101 @default.
- W4200480981 cites W2136709809 @default.
- W4200480981 cites W2138412449 @default.
- W4200480981 cites W2141566021 @default.
- W4200480981 cites W2154887758 @default.
- W4200480981 cites W2162401151 @default.
- W4200480981 cites W2164886443 @default.
- W4200480981 cites W2171278822 @default.
- W4200480981 cites W2463139428 @default.
- W4200480981 cites W2485662396 @default.
- W4200480981 cites W2530253449 @default.
- W4200480981 cites W2533003797 @default.
- W4200480981 cites W2588644629 @default.
- W4200480981 cites W2617035720 @default.
- W4200480981 cites W2735590725 @default.
- W4200480981 cites W2738161653 @default.
- W4200480981 cites W2753995352 @default.
- W4200480981 cites W2794139372 @default.
- W4200480981 cites W2805727714 @default.
- W4200480981 cites W2883340199 @default.
- W4200480981 cites W2888227984 @default.
- W4200480981 cites W2891777339 @default.
- W4200480981 cites W2894188334 @default.
- W4200480981 cites W2898770351 @default.
- W4200480981 cites W2899442720 @default.
- W4200480981 cites W2911899711 @default.
- W4200480981 cites W2921364326 @default.
- W4200480981 cites W2963643614 @default.
- W4200480981 cites W2995921055 @default.
- W4200480981 cites W3042792727 @default.
- W4200480981 cites W3115666119 @default.
- W4200480981 cites W3137878085 @default.
- W4200480981 cites W3161921875 @default.
- W4200480981 cites W3173074602 @default.
- W4200480981 cites W344068791 @default.
- W4200480981 cites W598738849 @default.
- W4200480981 cites W775311174 @default.
- W4200480981 cites W829805959 @default.
- W4200480981 cites W952491933 @default.
- W4200480981 doi "https://doi.org/10.1016/j.freeradbiomed.2021.12.304" @default.
- W4200480981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34954022" @default.
- W4200480981 hasPublicationYear "2022" @default.
- W4200480981 type Work @default.
- W4200480981 citedByCount "10" @default.
- W4200480981 countsByYear W42004809812022 @default.
- W4200480981 countsByYear W42004809812023 @default.
- W4200480981 crossrefType "journal-article" @default.
- W4200480981 hasAuthorship W4200480981A5004453115 @default.
- W4200480981 hasAuthorship W4200480981A5022559731 @default.
- W4200480981 hasAuthorship W4200480981A5032141337 @default.
- W4200480981 hasAuthorship W4200480981A5048396749 @default.
- W4200480981 hasAuthorship W4200480981A5053538919 @default.
- W4200480981 hasAuthorship W4200480981A5072661653 @default.